XML 28 R33.htm IDEA: XBRL DOCUMENT v3.19.3
Employee Benefit Plans (Tables)
9 Months Ended
Sep. 29, 2019
Employee Benefit and Share-based Payment Arrangement, Noncash Expense [Abstract]  
Schedule of Stock Option Activity
Stock option activity during the nine months ended September 29, 2019 was as follows:
 
Number of shares
 
Weighted Average Exercise Price Per Share
 
(In thousands)
 
(In dollars)
Outstanding as of December 31, 2018
1,969

 
$
25.30

Granted
502

 
$
26.61

Exercised
(226
)
 
$
20.31

Cancelled
(16
)
 
$
36.27

Expired
(15
)
 
$
40.00

Outstanding as of September 29, 2019
2,214

 
$
25.93


Schedule of RSU Activity
RSU activity during the nine months ended September 29, 2019 was as follows:
 
Number of shares
 
Weighted Average Grant Date Fair Value Per Share
 
(In thousands)
 
(In dollars)
Outstanding as of December 31, 2018
1,627

 
$
34.31

Granted
693

 
$
31.37

Vested
(535
)
 
$
31.62

Cancelled
(105
)
 
$
35.12

Outstanding as of September 29, 2019
1,680

 
$
33.90


Schedule of Weighted Average Assumptions
The table below sets forth the weighted average assumptions used to estimate the fair value of option grants and purchase rights granted during the three and nine months ended September 29, 2019 and September 30, 2018.
 
Three Months Ended
 
Nine Months Ended
 
Stock Options
 
ESPP
 
Stock Options
 
ESPP
 
September 29,
2019
 
September 30,
2018
 
September 29,
2019
 
September 30,
2018
 
September 29,
2019
 
September 30,
2018
 
September 29,
2019
 
September 30,
2018
Expected life (in years)
6.2

 
4.4

 
0.5

 
0.5

 
6.2

 
4.4

 
0.5

 
0.5

Risk-free interest rate
1.85
%
 
2.79
%
 
1.83
%
 
2.22
%
 
1.85
%
 
2.36
%
 
2.06
%
 
2.00
%
Expected volatility
33.9
%
 
33.5
%
 
44.5
%
 
38.8
%
 
33.9
%
 
31.1
%
 
43.9
%
 
37.9
%
Dividend yield

 

 

 

 

 

 

 


Schedule of Total Stock-Based Compensation Expense Resulting from Stock Options, Restricted Stock Awards, and the Employee Stock Purchase Plan
The following table sets forth the stock-based compensation expense resulting from stock options, RSUs and the ESPP included in the Company’s unaudited condensed consolidated statements of operations:
 
Three Months Ended
 
Nine Months Ended
 
September 29,
2019
 
September 30,
2018
 
September 29,
2019
 
September 30,
2018
 
(In thousands)
Cost of revenue
$
706

 
$
619

 
$
2,129

 
$
1,754

Research and development
1,496

 
1,037

 
3,976

 
3,171

Sales and marketing
2,097

 
1,970

 
6,223

 
6,363

General and administrative
2,687

 
2,492

 
7,855

 
8,940

Total stock-based compensation
$
6,986

 
$
6,118

 
$
20,183

 
$
20,228